Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion

Immunohematology

Volumn 28, Issue 1, 2012, Pages 7-12

  Roberts, Dionna O ^a   Covert, Brittany ^a   Lindsey, Terianne ^b   Edwards, Vincent ^c   McLaughlin, Lisa ^d   Theus, John ^c   Wray, Ricardo J ^e   Jupka, Keri ^e   Baker, David ^f   Robbins, Mary ^f   DeBaun, Michael R ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN RED CROSS   (United States)

^d HOLLAND LABORATORY   (United States)

^e SAINT LOUIS UNIVERSITY   (United States)

^f ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Alloimmunization; Blood transfusion; Donor exposure; Sickle cell disease

Indexed keywords

ADULT; ALLOIMMUNIZATION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MISSOURI; PROGRAM EVALUATION; YOUNG ADULT;

EID: 84862587550     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(4 Suppl):S512-21.
2. Isaak EJ, LeChien B, Lindsey T, Debaun MR. The Charles Drew program in Missouri: a description of a partnership among a blood center and several hospitals to address the care of patients with sickle cell disease. Immunohematology 2006;22:112-16.
3. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011;117:1130-40; quiz 1436.
4. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
5. Hulbert ML, Scothorn DJ, Panepinto JA, et al. Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. J Pediatr 2006;149:710-12.
6. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002;140:348-54.
7. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
8. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431-7.
9. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21.
10. Afenyi-Annan A, Willis MS, Konrad TR, Lottenberg R. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007;47:2089-97.
11. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562-9.
12. Castilho L, Rios M, Bianco C, et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion 2002;42:232-8.
13. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.
14. Osby M, Shulman IA. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005;129:190-3.
15. Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001;113:661-5.
16. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37-43.
17. Price CL, Boyd JH, Watkins AR, Fleming F, DeBaun MR. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion 2006;46:1388-93.
18. Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr 1974;2:328-35.
19. Steinberg D. Altruism in medicine: its definition, nature, and dilemmas. Camb Q Healthc Ethics 2010;19:249-57.
20. Lindsey T, Watts-Tate N, Southwood E, et al. Chronic blood transfusion therapy practices to treat strokes in children with sickle cell disease. J Am Acad Nurse Pract 2005;17:277-82.
21. Shaz BH, Demmons DG, Hillyer KL, Jones RE, Hillyer CD. Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med 2009;133:1444-7.
22. Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011;51:1732-9.
23. Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med 1978;65:461-71.
24. Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995;126:896-9.
25. McPherson ME, Anderson AR, Haight AE, et al. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. Transfusion 2009;49:1977-86.
26. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22:53-63.
27. Boulware LE, Ratner LE, Cooper LA, Sosa JA, LaVeist TA, Powe NR. Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care 2002;40:85-95.
28. Boulware LE, Ratner LE, Ness PM, et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 2002;42:669-78.
29. Shaz BH, James AB, Demmons DG, Schreiber GB, Hillyer CD. The African American church as a donation site: motivations and barriers. Transfusion 2010;50:1240-8.
30. Grossman B, Watkins AR, Fleming F, DeBaun MR. Barriers and motivators to blood and cord blood donations in young African-American women. Am J Hematol 2005;78:198-202.